SCHEMBL4814895

SCHEMBL4814895

CC1(C)C[CH]N(C(=O)Cc2ccc(-c3ccccc3)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.50
FAAH O00519 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 2/20 0.49
TSHR P16473 2/20 0.49
LMNA P02545 2/20 0.47
ABCC4 O15439 1/20 0.47
GAA P10253 1/20 0.47
PTGS1 P23219 1/20 0.47
HTT P42858 1/20 0.47
HRH3 Q9Y5N1 2/20 0.47
BCHE P06276 1/20 0.45
ALDH1A1 P00352 4/20 0.43
HPGD P15428 1/20 0.43
NPY5R Q15761 1/20 0.43
CASP3 P42574 1/20 0.42
CASP7 P55210 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4819758 0.91 ALDH1A1 (0.50) SMN1; SMN2TSHRLMNAGAABCHE
SCHEMBL4817869 0.82 HSD11B1 (0.47) SMN1; SMN2MAPTLMNAGAAALDH1A1
SCHEMBL4813567 0.79 POLB (0.48) SMN1; SMN2MAPTTSHRLMNAALDH1A1
SCHEMBL4814889 0.77 MAPT (0.59) NAAAFAAHSMN1; SMN2MAPTTSHR
SCHEMBL4817706 0.77 FAAH (0.56) NAAAFAAHSMN1; SMN2LMNAGAA
SCHEMBL4818095 0.72 MAPK1 (0.43) SMN1; SMN2TSHRLMNAGAAHTT
SCHEMBL11300270 0.70 FFAR2 (0.54) NAAAFAAHSMN1; SMN2MAPTTSHR
SCHEMBL4819128 0.69 ALDH1A1 (0.46) MAPTTSHRGAAALDH1A1KMT2A
Felbinac SCHEMBL7107700 0.67 LMNA (0.91) TSHRLMNAABCC4GAAPTGS1
SCHEMBL1928476 0.67 LMNA (0.69) SMN1; SMN2MAPTTSHRLMNAABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US claimed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP claimed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO claimed
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US disclosed